Hormonal agents used in lowering lipoprotein(a)

Maurizio R. Soma; Michele Meschìa; Fiorenza Bruschi; Joel D. Morrisett; Rodolfo Paoletti; R. Fumagalli; PierGiorgio Crosignani

doi:10.1016/0009-3084(94)90156-2

Hormonal agents used in lowering lipoprotein(a)

Maurizio R. Soma, Michele Meschìa, Fiorenza Bruschi, Joel D. Morrisett, Rodolfo Paoletti, R. Fumagalli, PierGiorgio Crosignani

In: Chemistry and Physics of Lipids · 1994 · vol. 67-68 , pp. 345–350 · doi:10.1016/0009-3084(94)90156-2 · PMID:8187233 · W2081395015

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

This paper reviews hormonal agents currently used for lowering lipoprotein(a) and discusses their mechanisms of action and clinical implications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid 1992

Cited by (1)

Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study 1996

References (32)

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid via openalex
doi:10.1136/bmj.303.6804.694 via openalex
doi:10.1097/00041433-199108000-00004 via openalex
doi:10.1172/jci115855 via openalex
doi:10.1001/archinte.1993.00410120044006 via openalex
doi:10.1016/0140-6736(91)91674-j via openalex
doi:10.1161/01.cir.84.1.160 via openalex
doi:10.1001/archinte.153.12.1462 via openalex
W2424129053 via openalex
doi:10.1016/s0002-9378(11)90604-8 via openalex
W6661324837 via openalex
W6677049905 via openalex
W6755359322 via openalex
doi:10.1016/0005-2760(84)90078-x via openalex
doi:10.1016/0021-9150(92)90271-h via openalex
doi:10.1016/0378-5122(88)90063-1 via openalex
doi:10.1056/nejm199109123251102 via openalex
doi:10.2307/2556182 via openalex
doi:10.1161/01.cir.74.4.758 via openalex
doi:10.1016/0026-0495(86)90150-2 via openalex
doi:10.1515/cclm.1984.22.9.591 via openalex
doi:10.1161/01.atv.13.8.1139 via openalex
doi:10.1172/jci114625 via openalex
doi:10.1016/b978-0-12-620990-7.50017-6 via openalex
doi:10.1093/oxfordjournals.bmb.a072548 via openalex
doi:10.1161/01.atv.11.1.23 via openalex
doi:10.1056/nejm199203053261012 via openalex
doi:10.1146/annurev.me.43.020192.001323 via openalex
doi:10.1161/01.atv.10.5.672 via openalex
doi:10.1126/science.2530631 via openalex
doi:10.1016/0076-6879(86)29068-0 via openalex
doi:10.1001/jama.267.8.1109 via openalex

Cited by (1)

Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study 1996

Source provenance

openalex: last seen: 2026-05-14T06:09:40.812857+00:00

License: CC0 · commercial use OK

[1] Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid 1992